StonvexLoading…
StonvexStonvexStonvexCore line items from MHK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-22 | Q2 2026 2026-04-04 | Annual 2025 2025-12-31 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|---|
Revenue | $2.82B | $2.73B | $10.79B | $8.09B | $5.33B |
Operating Income | Not available | $111.80M | $489.80M | $421.50M | $284.80M |
Net Income | Not available | $117.10M | $369.90M | $327.90M | $219.00M |
EPS (Diluted) | $2.61 | $1.90 | $5.93 | $5.24 | $3.49 |
Total Assets | Not available | $13.79B | $13.69B | $13.62B | $13.78B |
Total Liabilities | Not available | $5.41B | $5.31B | $5.28B | $5.48B |
Cash & Equivalents | Not available | $872.30M | $856.10M | $516.20M | $546.70M |
Free Cash Flow OCF − CapEx | Not available | $7.80M | $616.20M | $351.00M | $40.70M |
Shares Outstanding | Not available | 61.70M | 62.40M | 62.60M | 62.70M |